Secondary cytoreductive surgery outcomes of selected patients with paclitaxel/platinum sensitive recurrent epithelial ovarian cancer

Journal of Surgical Oncology

Volumn 106, Issue 4, 2012, Pages 369-375

  Boran, Nurettin ^a   Hizli, Deniz ^a   Yilmaz, Saynur ^a   Turan, Taner ^a   Celik, Bülent ^b   Karabuk, Emine ^a   Isikdogan, Zuhal ^c   Tulunay, Gökhan ^a   Kose, M Faruk ^a  

^a Etlik Zubeyde Hanim Women's Health Teaching and Research Hospital   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

^c Etlik Zubeyde Hanim Women's Health Teaching and Research Hospital   (Turkey)

Author keywords

epithelial ovarian cancer; paclitaxel platinum sensitive; prognostic factors; secondary cytoreductive surgery; survival

Indexed keywords

CA 125 ANTIGEN; PACLITAXEL; PLATINUM;

ADULT; AGED; ARTICLE; ASCITES; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CYTOREDUCTIVE SURGERY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; OVARY CARCINOMA; PRIORITY JOURNAL; RECURRENT CANCER; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CA-125 ANTIGEN; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PACLITAXEL; PLATINUM; TREATMENT OUTCOME;

EID: 84865137224     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23094     Document Type: Article

References (29)

1. Zang RY, Li ZT, Tang J, et al.: Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: Who benefits ? Cancer 2004; 100: 1152-1161. (Pubitemid 38325942)
2. McGuire WP, Hoskins WJ, Brady MF, et al.: Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996; 334: 1-6. (Pubitemid 26012496)
3. Bristow RE, Tomacruz RS, Armstrong DK, et al.: Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis. J Clin Oncol 2002; 20: 1248-1259. (Pubitemid 34177431)
4. Ozols RF:, Recurrent ovarian cancer: Evidence-based treatment. J Clin Oncol 2002; 20: 1161-1163. (Pubitemid 34177419)
5. Eisenkop SM, Friedman RL, Wang HJ:, Secondary cytoreductive surgery for recurrent ovarian cancer. Cancer 1995; 76: 1606-1614.
6. Janicke F, Holscher M, Kuhn W, et al.: Radical surgical procedure improves survival time in patients with ovarian cancer. Cancer 1992; 70: 2129-2136.
7. Vaccarello L, Rubin SC, Vlamis V, et al.: Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response. Gynecol Oncol 1995; 57: 61-65.
8. Morris M, Gershenson DM, Wharton T, et al.: Secondary cytoreductive surgery for epithelial ovarian cancer. Gynecol Oncol 1989; 34: 334-338. (Pubitemid 19218573)
9. Tay EH, Grant PT, Gebski V, et al.: Secondary cytoreductive surgery for recurrent epithelial ovarian cancer. Obstet Gynecol 2002; 99: 1008-1013. (Pubitemid 34621223)
10. Salani R, Santillan A, Zahurak ML, et al.: Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: Analysis of prognostic factors and survival outcome. Cancer 2007; 109: 685-691. (Pubitemid 46233229)
11. Schorge JO, Wingo SN, Bhore R, et al.: Secondary cytoreductive surgery for recurrent platinum-sensitive ovarian cancer. Int J Gynaecol Obstet 2010; 108: 123-127. Epub 2009 Nov 4.
12. Zang RY, Zhang ZY, Li ZT, et al.: Effect of cytoreductive surgery on survival of patients with recurrent epithelial ovarian cancer. J Surg Oncol 2000; 75: 24-30.
13. Park JY, Eom JM, Kim DY, et al.: Secondary cytoreductive surgery in the management of platinum-sensitive recurrent epithelial ovarian cancer. J Surg Oncol 2010; 101: 418-424.
14. Bae J, Lim MC, Choi JH, et al.: Prognostic factors of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer. J Gynecol Oncol 2009; 20: 101-106. Epub 2009 Jun 29.
15. Gungor M, Ortac F, Arvas M, et al.: The role of secondary cytoreductive surgery for recurrent ovarian cancer. Gynecol Oncol 2005; 97: 74-79. (Pubitemid 40403677)
16. Scarabelli C, Gallo A, Carbone A:, Secondary cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma. Gynecol Oncol 2001; 83: 504-512. (Pubitemid 33139711)
17. Cormio G, di Vagno G, Cazzolla A, et al.: Surgical treatment of recurrent ovarian cancer: Report of 21 cases and a review of the literature. Eur J Obstet Gynecol Reprod Biol 1999; 86: 185-188. (Pubitemid 29391484)
18. Eisenkop SM, Friedman RL, Spirtos NM:, The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma. Cancer 2000; 88: 144-153. (Pubitemid 30027690)
19. Munkarah AR, Coleman RL:, Critical evaluation of secondary cytoreduction in recurrent ovarian cancer. Gynecol Oncol 2004; 95: 273-280. (Pubitemid 39445861)
20. Rose PG, Nerenstone S, Brady MF, et al.: Secondary surgical cytoreduction for advanced ovarian carcinoma. N Engl J Med 2004; 351: 2489-2497.
21. Tebes SJ, Sayer RA, Palmer JM, et al.: Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma. Gynecol Oncol 2007; 106: 482-487. Epub 2007 Jun 27. (Pubitemid 47302452)
22. Chi DS, McCaughty K, Diaz JP, et al.: Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma. Cancer 2006; 106: 1933-1939. (Pubitemid 43673208)
23. Bristow RE, Puri I, Chi DS:, Cytoreductive surgery for recurrent ovarian cancer: A meta-analysis. Gynecol Oncol 2009; 112: 265-274.
24. Landoni F, Pellegrino A, Cormio G, et al.: Platin-based chemotherapy and salvage surgery in recurrent ovarian cancer following negative second-look laparotomy. Acta Obstet Gynecol Scand 1998; 77: 233-237. (Pubitemid 28075397)
25. Munkarah A, Levenback C, Wolf JK, et al.: Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer. Gynecol Oncol 2001; 81: 237-241. (Pubitemid 32424168)
26. Benedetti Panici P, De Vivo A, Bellati F, et al.: Secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer. Ann Surg Oncol 2007; 14: 1136-1142.
27. Zang RY, Harter P, Chi DS, et al.: Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort. Br J Cancer 2011; 105: 890-896.
28. Berek JS, Hacker NF, LaGasse LD, et al.: Survival of patients following secondary cytoreductive surgery in ovarian cancer. Obstet Gynecol 1983; 61: 189-193. (Pubitemid 13110698)
29. Fotiou S, Aliki T, Petros Z, et al.: Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer. Gynecol Oncol 2009; 114: 178-182.